Rosewood (Aniba rosaeodora Ducke) oil in broiler chickens diet

O estudo foi conduzido para investigar os efeitos do óleo essencial de pau rosa sobre o desempenho, rendimento de carcaça e cortes comerciais e microbiologia do trato gastrintestinal de frangos de corte. Foram utilizados 540 pintos machos de um dia de idade, distribuídos num delineamento inteiramente casualizado com seis tratamentos e seis repetições de 15 aves cada. Os tratamentos consistiram em: níveis de inclusão de 0,00mL (0,00 EO); 0,15mL (0,15 EO); 0,30mL (0,30 EO); 0,45mL (0,45 EO) e 0,60mL (0,60 EO) de óleo essencial de pau rosa/kg de ração e controle (promotor comercial virginiamicina). Aos 21 e 40 dias de idade, não foram observadas diferenças significativas para peso corporal, consumo de ração, conversão alimentar e viabilidade das aves quando comparado o tratamento controle e os diferentes níveis de inclusão de RO. Os rendimentos de carcaça e de cortes comerciais não foram influenciados pelos tratamentos. O aumento do nível de inclusão de RO diminuiu o peso relativo dos intestinos. O promotor de crescimento teve maior concentração de Escherichia coli na digesta intestinal quando comparado com 0,00 EO e 0,30 EO. Conclui-se que o óleo essencial de pau rosa não afeta o desempenho e rendimento de abate, reduz o peso relativo dos intestinos. O RO mostra atividade antimicrobiana consistente contra Escherichia coli.

Effect of copaiba essential oil on broiler chickens' performance

Um estudo foi conduzido para avaliar os efeitos do óleo essencial de copaíba sobre o desempenho e rendimento de abate de frangos de corte. Foram utilizados 450 pintos, distribuídos num delineamento inteiramente casualizado com 5 tratamentos e 6 repetições de 15 aves. Os tratamentos consistiram em Controle (promotor comercial) e quatro níveis de óleo essencial de copaíba sendo estes 0,15 (0,15EO); 0,30 (0,30EO); 0,45 (0,45EO) e 0,60 mL (0,60EO) kg^-1 de ração. Aos 21 dias de idade, as aves do tratamento com promotor apresentaram peso corporal superior ao das aves que receberam os tratamentos com 0,30; 0,45 e 0,60 mL de inclusão de óleo essencial (p < 0,05). Aos 40 dias de idade apenas as aves que receberam o tratamento com maior nível de inclusão de óleo essencial apresentaram menor peso corporal em relação ao tratamento com promotor de crescimento. O consumo de ração, a conversão alimentar e a viabilidade das aves, assim como o rendimento de carcaça, cortes comerciais e peso dos órgãos internos não foram afetados pelos tratamentos (p > 0.05). Conclui-se que o óleo essencial de copaíba pode ser usado na ração até o nível de 0,15 mL kg^-1 sem afetar o desempenho das aves.

Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from North Brazil

We have examined the prevalence of gene cagA and vacA alleles in 129 patients, 69 with gastritis and 60 with peptic ulcer diseases from North Brazil and their relation with histopathological data. vacA and cagA genotype were determined by polymerase chain reaction. Hematoxylin-eosin staining was used for histological diagnosis. 96.6% of the patients were colonized by Helicobacter pylori strains harboring single vacA genotype (nont-mixed infection). Among them, 11.8% had subtype s1a, 67.8% had subtype s1b, and 17% subtype s2. In regard to the middle region analysis, m1 alleles were found in 75.4% and m2 in 21.2% of patients. The cagA gene was detected in 78% patients infected with H. pylori and was associated with the s1-m1 vacA genotype. The H. pylori strains, vacA s1b m1/cagA-positive, were associated with increased risk of peptic ulcer disease and higher amounts of lymphocytic and neutrophilic infiltrates and the presence of intestinal metaplasia. These findings show that cagA and vacA genotyping may have clinical relevance in Brazil.

Oxidative stress and antioxidant status in beta-thalassemia heterozygotes

Background: Several studies have evaluated the oxidant and antioxidant status of thalassemia patients but most focused mainly on the severe and intermediate states of the disease. Moreover, the oxidative status has not been evaluated for the different beta-thalassemia mutations. Objective: To evaluate lipid peroxidation and Trolox equivalent antioxidant capacity in relation to serum iron and ferritin in beta thalassemia resulting from two different mutations (CD39 and IVS-I-110) compared to individuals without beta-thalassemia. Methods: One hundred and thirty subjects were studied, including 49 who were heterozygous for beta-thalassemia and 81 controls. Blood samples were subjected to screening tests for hemoglobin. Allele-specific polymerase chain reaction was used to confirm mutations for beta-thalassemia, an analysis of thiobarbituric acid reactive species was used to determine lipid peroxidation, and Trolox equivalent antioxidant capacity evaluations were performed. The heterozygous beta-thalassemia group was also evaluated for serum iron and ferritin status. Results: Thiobarbituric acid reactive species (486.24 ± 119.64 ng/mL) and Trolox equivalent antioxidant capacity values (2.23 ± 0.11 mM/L) were higher in beta-thalassemia heterozygotes compared to controls (260.86 ± 92.40 ng/mL and 2.12 ± 0.10 mM/L, respectively; p-value < 0.01). Increased thiobarbituric acid reactive species values were observed in subjects with the CD39 mutation compared with those with the IVS-I-110 mutation (529.94 ± 115.60 ng/mL and 453.39 ± 121.10 ng/mL, respectively; p-value = 0.04). However, average Trolox equivalent antioxidant capacity values were similar for both mutations (2.20 ± 0.08 mM/L and 2.23 ± 0.12 mM/L, respectively; p-value = 0.39). There was no influence of serum iron and ferritin levels on thiobarbituric acid reactive species and Trolox equivalent antioxidant capacity values. Conclusion: This study shows an increase of oxidative stress and antioxidant capacity in beta-thalassemia heterozygotes, mainly in carriers of the CD39 mutation.